NLS Pharmaceutics Ltd. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company is headquartered in Zurich, Zuerich and currently employs 1 full-time employees. The company went IPO on 2021-01-29. The firm focuses on development of medicines for neurobehavioral and neurocognitive disorders treatment. The firm serves customers worldwide.
Follow-Up Questions
NLS Pharmaceutics AG 的 CEO 是誰？
Mr. Alexander Zwyer 是 NLS Pharmaceutics AG 的 Chief Executive Officer，自 2015 加入公司。
NLSP 股票的價格表現如何？
NLSP 的當前價格為 $2.02，在上個交易日 decreased 了 1.67%。
NLS Pharmaceutics AG 的主要業務主題或行業是什麼？
NLS Pharmaceutics AG 屬於 Pharmaceuticals 行業，該板塊是 Health Care
